The sensitivity of INSM1 was found to be 80.0%, thus indicating its role as a valuable marker of neuroendocrine differentiation in both primary and metastatic neuroendocrine neoplasms [34, 35]. This evidence concerns the gene INSM1 and neuroendocrine neoplasm.